Sort
78,016 grants matching “breast cancer”
Novel Enediyne-Based Antibody-Drug Conjugates for Cancers
$658,973Ben Shen · Scripps Florida · R01 · FY2018 · CA
Novel Enediyne-Based Antibody-Drug Conjugates for Cancers
$658,973Ben Shen · Scripps Florida · R01 · FY2020 · CA
NEW EPIGENETIC THERAPEUTIC INTERVENTION FOR METASTATIC BREAST CANCER
$658,900University Of Kentucky Research Foundation, The · · FY2015 · Department of the Army
BREAST CANCER SELECTIVE THERAPEUTIC DEVELOPMENT: LEAD OPTIMIZATION OF A SMALL-MOLECULE INHIBITOR OF THE BREAST CANCER SELECTIVE HUB PROTEIN CAPCNA
$658,813Regents Of The University Of California At Riverside · · FY2019 · Defense Health Agency
Multi-Modality Quantitiative Imaging for Evaluation of Response to Cancer Therapy
$658,727Eric C. Frey · Johns Hopkins University · U01 · FY2015 · CA
Increasing breast cancer chemoprevention in the primary care setting
$658,722Katherine D Crew · Columbia University Health Sciences · R01 · FY2014 · CA
Bone Microarchitecture: The Framingham Osteoporosis Study
$658,717Douglas P. Kiel · Hebrew Rehabilitation Center For Aged · R01 · FY2012 · AR
Depo-Provera and Breast Cancer: Epidemiology/Pathology
$658,665Christopher I Li · Fred Hutchinson Cancer Research Center · R01 · FY2006 · CA
Integrating Epigenetic Modulation into DNA Damage Repair
$658,646Pamela N Munster · University Of California, San Francisco · R01 · FY2025 · CA
ABI Innovation: Empirical Dynamics: A Next-Generation Approach For Uncovering Hidden Causal Links in Gene Expression
$658,634George Sugihara · University Of California-San Diego Scripps Inst Of Oceanography · · FY2017 · BIO
RCT of exercise on aromatase inhibitor side effects in breast cancer survivors
$658,614Melinda L Irwin · Yale University · R01 · FY2010 · CA
Clinical Utility of Salivary ExRNA Biomarkers for Gastric Cancer Detection
$658,595David T Wong · University Of California Los Angeles · UH3 · FY2017 · TR
Targeted MDM2 degradation for improved treatment for triple-negative breast cancer
$658,561Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2025 · CA
Feasibility and Assessment of a Cascade Traceback Screening program - FACTS
$658,560Adam H Buchanan · Geisinger Clinic · U01 · FY2023 · CA
Affinity-based Seurm Proteomics: Breast/Ovarian Cancer
$658,549Martin W McIntosh · Fred Hutchinson Cancer Research Center · U01 · FY2008 · CA
NANOVECTORS FOR TARGETING AND DELOVERY OF THERAPEUTICS TO HER-2 NEU POSITIVE BREAST CANCER CELLS
$658,440The Methodist Hospital Research Institute · · FY2008 · Department of the Army
Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA
$658,396Miriam C Poirier · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis
$658,336Tad George · Rarecyte, Inc. · R44 · FY2025 · CA
Improving Delivery of Genetic Services to High Risk Childhood Cancer Survivors: A Randomized Study of Remote Genetic Services Versus Usual Care
$658,129Tara Olive Henderson · University Of Chicago · R01 · FY2023 · CA
Clinical production of viral vectors for cancer gene therapy
$658,126Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
Eukaryotic Chromosome Replication
$658,114Bonita J Brewer · University Of Washington · R01 · FY2014 · GM
VERMONT BREAST CANCER SURVEILLANCE SYSTEM
$658,051University Of Vermont &St Agric College · U01 · FY2004 · CA
Impact of BRCA Testing on Newly Diagnosed U.S. Breast Cancer Patients
$657,997Rebecca Sutphen · University Of South Florida · R01 · FY2016 · CA
Neurocognitive and Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell Therapy: A Controlled Comparison
$657,991Heather S.l. Jim · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Biological functions of chromosomal proteins
$657,985Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA